Harmony Biosciences Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Plymouth Meeting, PA
HRMY chart
What traders are saying about $HRMY
Latest postsHarmony Biosciences Holdings, Inc. news
- Harmony Biosciences (HRMY) Gains Investor Attention with Strong Revenue Growth and Attractive Valuation
GuruFocus ·
- Harmony Biosciences Sets November 4 Earnings Report
MyChesCo ·
- BHC Q3 Earnings Preview: Here's What You Should Know
Yahoo Finance ·
- TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
Yahoo Finance ·
- RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall
Yahoo Finance ·
- 4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hike
marketbeat.com ·
- Harmony Biosciences Holdings, Inc. Estimates – NASDAQ:HRMY
TradingView ·
- Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Harmony Biosciences shares drop 7% amid patent dispute closing arguments over drug Wakix
Pluang ·
- Mizuho reiterates Harmony Biosciences stock rating after litigation
Investing.com ·
- HRMY or ARGX: Which Is the Better Value Stock Right Now?
Yahoo Finance ·
- Centene, Harmony Biosciences lead list of undervalued healthcare stocks (XLV:NYSEARCA)
Seeking Alpha ·
Harmony Biosciences Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $868.5M | $714.7M | $582.0M | $437.9M |
| Net income | $158.7M | $145.5M | $128.9M | $181.5M |
| Diluted EPS | $2.71 | $2.51 | $2.13 | $2.97 |
| Total assets (year end) | $1.27B | $999.2M | $811.4M | $673.9M |
| Cash and equivalents (year end) | $752.5M | $453.0M | $311.7M | $243.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Harmony Biosciences Holdings, Inc.
- Ticker
- HRMY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Plymouth Meeting, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1802665
Frequently asked questions
What exchange is Harmony Biosciences Holdings, Inc. listed on?
Harmony Biosciences Holdings, Inc. trades on the Nasdaq under the ticker symbol HRMY.
What industry is Harmony Biosciences Holdings, Inc. in?
Harmony Biosciences Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Harmony Biosciences Holdings, Inc. headquartered?
Harmony Biosciences Holdings, Inc.'s business address on file with the SEC is in Plymouth Meeting, PA.
When does Harmony Biosciences Holdings, Inc.'s fiscal year end?
Harmony Biosciences Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Harmony Biosciences Holdings, Inc. report?
Harmony Biosciences Holdings, Inc. reported $868.5M in revenue for calendar year 2025, according to its SEC filings.